Abbonarsi

Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting - 07/12/23

Doi : 10.1016/j.jaci.2023.08.021 
Mirna Chehade, MD, MPH a, , Benjamin L. Wright, MD b, c, Dan Atkins, MD d, Seema S. Aceves, MD, PhD e, f, Steven J. Ackerman, PhD g, Amal H. Assa’ad, MD h, Maureen Bauer, MD d, Margaret H. Collins, MD h, Scott P. Commins, MD, PhD i, Carla M. Davis, MD j, k, Evan S. Dellon, MD l, Bethan Doerfler, RDN m, Gerald J. Gleich, MD n, Sandeep K. Gupta, MD, PhD o, David A. Hill, MD, PhD p, q, Elizabeth T. Jensen, PhD r, David Katzka, MD s, Kara Kliewer, PhD h, Ellyn Kodroff t, Leah C. Kottyan, PhD u, Shay Kyle t, Amanda B. Muir, MD p, q, Robert D. Pesek, MD v, w, Kathryn Peterson, MD x, Wayne G. Shreffler, MD, PhD y, z, aa, Jonathan M. Spergel, MD, PhD p, q, Mary Jo Strobel bb, Joshua Wechsler, MD cc, Nives Zimmermann, MD h, Glenn T. Furuta, MD d, Marc E. Rothenberg, MD, PhD h
a Mount Sinai Center for Eosinophilic Disorders, Icahn School of Medicine at Mount Sinai, New York, NY 
b Division of Allergy, Asthma, and Clinical Immunology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, Ariz 
c Section of Allergy and Immunology, Division of Pulmonology, Phoenix Children’s Hospital, Phoenix, Ariz 
d Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo 
e Rady Children’s Hospital, San Diego, Calif 
f Division of Allergy, Immunology, University of California-San Diego, San Diego, Calif 
g Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, Ill 
h Cincinnati Children’s Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio 
i Division of Allergy & Immunology, Center for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC 
j Division of Immunology, Allergy, and Retrovirology, Baylor College of Medicine, Houston, Tex 
k Texas Children’s Hospital Food Allergy Program, Texas Children’s Hospital, Houston, Tex 
l Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, NC 
m Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Chicago, Ill 
n Department of Dermatology, School of Medicine, University of Utah School of Medicine, Salt Lake City, Utah 
o Children’s of Alabama, University of Alabama at Birmingham, Birmingham, Ala 
p Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pa 
q Division of Allergy and Immunology, Children’s Hospital of Philadelphia, Philadelphia, Pa 
r Wake Forest University School of Medicine, Winston-Salem, NC 
s Division of Digestive and Liver Diseases, Columbia University Irving Medical Center, New York, NY 
t Campaign Urging Research for Eosinophilic Disease, Lincolnshire, Ill 
u Cincinnati Children’s Research Foundation, Division of Human Genetics, Center for Autoimmune Genomics and Etiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio 
v Division of Allergy/Immunology, University of Arkansas for Medicine Sciences, Little Rock, Ark 
w Arkansas Children’s Hospital, Little Rock, Ark 
x Division of Gastroenterology, University of Utah Health, Salt Lake City, Utah 
y Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, Mass 
z Harvard Medical School, Massachusetts General Hospital, Boston, Mass 
aa Food Allergy Center, Massachusetts General Hospital, Boston, Mass 
bb American Partnership for Eosinophilic Disorders, Atlanta, Ga 
cc Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, Ill 

Corresponding author: Mirna Chehade, MD, MPH, Mount Sinai Center for Eosinophilic Disorders, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1198, New York, NY 10029.Mount Sinai Center for Eosinophilic DisordersIcahn School of Medicine at Mount SinaiOne Gustave L. Levy PlaceBox 1198New YorkNY10029

Abstract

The Consortium of Eosinophilic Gastrointestinal Diseases and The International Gastrointestinal Eosinophil Researchers organized a day-long symposium at the 2022 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured a review of recent discoveries in the basic biology and pathogenesis of eosinophilic gastrointestinal diseases (EGIDs) in addition to advances in our understanding of the clinical features of EGIDs. Diagnostic and management approaches were reviewed and debated, and clinical trials of emerging therapies were highlighted. Herein, we briefly summarize the breakthrough discoveries in EGIDs.

Il testo completo di questo articolo è disponibile in PDF.

Key words : Eosinophilic esophagitis, eosinophilic gastritis, eosinophil, food allergy

Abbreviations used : CEGIR, EED, EGID, EG-REFS, EoC, EoE, EoEHSS, EoG, EoN, eos/hpf, FDA, OIT, SCIT


Mappa


© 2023  American Academy of Allergy, Asthma & Immunology. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 152 - N° 6

P. 1382-1393 - dicembre 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • The SARS-CoV-2 pandemic and asthma: What we have learned and what is still unknown
  • Christa McPhee, Kateryna Yevdokimova, Linda Rogers, Monica Kraft
| Articolo seguente Articolo seguente
  • The role of Janus kinase signaling in the pathology of atopic dermatitis
  • Emma Guttman-Yassky, Alan D. Irvine, Patrick M. Brunner, Brian S. Kim, Mark Boguniewicz, Julie Parmentier, Andrew M. Platt, Kenji Kabashima

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.